V
The startup develops adjuvant-infused, needle-free, and cold chain-free nasal vaccines to enhance the efficacy of vaccines against infectious diseases, cancer, and chronic metabolic disorders. By utilizing advanced peptide technology, the company aims to improve global immunization rates and provide healthcare providers with effective therapeutic options.
Updated 2 months ago
Funding
Funding not disclosed
Funding rounds are not available yet.
Founders
Founder details are not available yet.
Product
Features
- The startup develops adjuvant-infused, needle-free, and cold chain-free nasal vaccines to enhance the efficacy of vaccines against infectious diseases, cancer, and chronic metabolic disorders. By utilizing advanced peptide technology, the company aims to improve global immunization rates and provide healthcare providers with effective therapeutic options.